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Abstract
Background: The aims of this study were to assess the knowledge, attitudes, and behaviors towards seasonal
influenza and its vaccination among pregnant women.
Methods: A cross-sectional survey was carried out among a sample of women in the second or third trimester of
pregnancy in Italy.
Results: The 64.2% of the sample knew that the influenza is more dangerous for pregnant women. Women of
older age, Italian, and who had a pregnancy at high-risk were more likely to have this knowledge. This knowledge
was lower among women with none, primary or secondary school education. The majority of the respondents
considered the vaccine not very useful during pregnancy. Those younger, unmarried, who knew that influenza is
more dangerous for pregnant women, who knew that the vaccine could protect them, who reported a
higher self-rated health status, and who had received information about influenza and its vaccination were
more likely to have a positive attitude toward the usefulness of influenza vaccination in pregnancy. Women
with secondary school education and with more than one child revealed a lower perception. Only 9.7% had
received the vaccine and 21.4% of those unvaccinated would be willing to receive it. This positive attitude
was higher among women with one child, who knew that the vaccine could protect them against the
influenza, and who have a positive attitude toward the usefulness of the vaccination during pregnancy.
Conclusions: Health educational programs are needed to improve the knowledge about seasonal influenza
and vaccination rate in pregnancy.
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Background
The seasonal influenza is one of the most frequent infec-
tions and pregnant women are at high risk with higher
healthcare service use, morbidity and mortality especially
in presence of chronic conditions [1–3].
The World Health Organization recommend the ad-
ministration of the vaccine in healthy women who are, at
the beginning of the influenza season, in the second or
third trimester of pregnancy or with concomitant chronic
conditions in any stage of gestation [2]. However, despite
the availability of a safe and effective influenza vaccine for
both the mother and the unborn [4–11], the vaccination
rate in pregnant women is disappointingly low [12–15]. In
Italy, the vaccination is recommended free of charge for
those in the second and third trimester during the
epidemic period [16].
Several studies have investigated the level of know-
ledge and the attitudes among pregnant women about
seasonal influenza and its vaccination [17–26] and this
is extremely important in order to develop strategies to
improve vaccination rates. Indeed, women with higher
knowledge regarding the usefulness of the vaccination
are more willing to receive the vaccine during pregnancy
[27–29] and the uptake is influenced by the low percep-
tion of the risks related to influenza [17, 20, 30, 31]. To
date, there has been very little research concerning the
level of knowledge and behaviors regarding seasonal
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influenza and the associated factors among pregnant
women in Italy [32]. Therefore, the present survey was
performed to achieve two primary objectives. The first
objective was to assess the knowledge, attitudes, and be-
haviors towards seasonal influenza and its vaccination
among pregnant women in Italy, and the second was to
evaluate the determinants of knowledge and attitudes to-
wards influenza vaccination.
Methods
Study setting and population
A cross-sectional survey design has been used, recruiting
women in the second or third trimester of pregnancy be-
tween December 2015 and February 2016 attending
Obstetrics ambulatory centers in public non-teaching
hospitals in the geographic area of Naples, Italy. A two
stages cluster sampling strategy has been used. Firstly,
from the list of all public non-teaching hospitals in
Naples, two hospitals have been randomly selected.
Then, from each hospital a random sample of pregnant
women has been recruited. Sample size was estimated
assuming an expected positive attitude towards willing-
ness to receive the influenza vaccine during the preg-
nancy of 30%, a confidence interval of 95%, and an error
of 5%. The required sample was estimated in 370 preg-
nant women. In order to select a representative sample
of the population, assuming a 10% non-response rate,
the final sample size was 410 pregnant women.
Procedure
The director of the selected hospitals received a letter
requesting permission to carry out the survey, clarifying
the purposes, the methods of collecting information, and
the anonymity and confidentiality of the data. Eligible
pregnant women in the second or third trimester of
pregnancy aged 18 years or older attending the selected
ambulatories were approached by one of the investiga-
tors before the clinical consultation and they were asked
to complete an anonymous, face-to-face interview. Prior
the interview, pregnant women were given information
about the aims of the study, details about the data col-
lection instrument, the anonymity of the interview, and
that the data would be treated with respect of privacy.
Signed consent form from each participant was obtained
prior to data collection. Data was collected in the wait-
ing room of the ambulatory center. Participation was
voluntary and no payment or incentives has been given.
Instrument
The face-to-face structured questionnaire [Additional file 1:
Questionnaire] comprised the following five sections: (i)
socio-demographic (age, educational level, marital status,
number of children, employment status, medical history,
self-rated health status) and pregnancy characteristics
(number of pregnancies, parity, gravid, week of pregnancy);
(ii) knowledge regarding influenza and its vaccination dur-
ing pregnancy (risk of contract influenza, vaccination as
preventive measure, vaccine recommendation, safety of the
vaccine). Response options included “true,” “false,” or “do
not know”; (iii) attitude towards the influenza and its vac-
cination during pregnancy (concern about contract influ-
enza, usefulness of the vaccine, safety of the vaccine,
intention for getting or not getting the vaccination). The at-
titudes were measured with a 10-point Likert scale ranging
from 1 to 10; (iv) behaviors regarding influenza vaccination
in previous or current pregnancy (whether or not they had
received vaccination, whether or not they had received ad-
vice by the physicians to receive the vaccination). Response
options included “yes” and “no”, and for each response a
choice from a list of reasons; (v) sources of information
about influenza and its vaccination.
A pilot study was conducted with 25 pregnant women
(not included in the final sample) to determine the com-
prehensibility of each question. The protocol was pre-
sented and approved by the Human Research Ethical
Committee of the Second University of Naples.
Statistical analysis
The software Stata version 10.1 was used to perform all
statistical analysis [33]. The first level of analysis com-
prised descriptive statistics of the main socio-
demographic and pregnancy characteristics of the sam-
ple and of the different questions. The second level of
analysis has been completed in two stages. Firstly, a bi-
variate analysis was carried out to assess the association
between each independent variable and the different
outcomes of interest using chi-square test for the cat-
egorical variables and Student’s t-test for the continuous
variables. Secondly, multivariate analysis was performed.
Multivariate logistic regression analysis was conducted
to identify independent characteristics associated with
the following dichotomous outcome variables: know-
ledge that influenza is more dangerous for pregnant
women compared to non-knowledge (Model 1) and posi-
tive attitude towards willingness to receive the influenza
vaccine in pregnancy compared to non-positive attitude
(Model 3). A multivariate linear regression analysis was per-
formed for the continuous outcome variable positive atti-
tude towards the usefulness of the influenza vaccine during
pregnancy (Model 2). The following characteristics of each
respondent were included in all models: age (continuous, in
years), highest level of education (three categories: none or
primary school = 0; secondary school = 1; college degree or
higher = 2), Italian nationality (no = 0; yes = 1), marital sta-
tus (single/separated/divorced/widowed = 0; married = 1),
number of children (none = 0; one = 1; more than one = 2),
having a high-risk pregnancy (no = 0; yes = 1), and having
received information about influenza and its vaccination
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during pregnancy (no = 0; yes = 1). Moreover, self-
rated health status (continuous), knowledge that influ-
enza is more dangerous for pregnant women than for
those who are not pregnant (no = 0; yes = 1), know-
ledge that the vaccine could protect pregnant women
against influenza (no = 0; yes = 1), and perceive dan-
gerous for the unborn if the women contract the in-
fluenza during pregnancy (continuous) were included
in Models 2 and 3. Finally, positive attitude towards
the usefulness of the vaccine during pregnancy (con-
tinuous) was included in Model 3.
A stepwise procedure was used to obtain the final
models according with p values for the variable inclusion
and exclusion in the models respectively of >0.2 and
<0.4. Odds ratios (ORs) and 95% confidence intervals
(CIs) were calculated in the multivariate logistic regres-
sion analysis, and standardized regression coefficients
(ß) were presented in the linear regression model. A
two-tailed p-value of less than 0.05 was used to define
statistical significance.
Results
Out of the 410 pregnant women selected, 372 consented
to participate for an overall response rate of 90.7%. The
main socio-demographic and pregnancy characteristics of
the sample are reported in Table 1. The mean age was
29 years, two thirds (67.5%) reported the secondary school
as highest education, the large proportion was married,
one third has at least one child, the average gestation was
27 weeks, the 12.9% had a high-risk pregnancy, and the
mean self-rated health status value was 7.1.
When it was asked about the seasonal influenza and its
vaccination, 64.2% of the sample correctly answered that
the influenza is more dangerous for pregnant women than
for non-pregnant, 40.9% that the vaccine could protect
pregnant women, one in four that vaccination was recom-
mended during pregnancy, while only 11.2% and 7.9% of
them correctly answered that it was recommended in the
second or third trimester of pregnancy (Table 2). Table 3
presents the multivariate logistic and linear regression
analysis of factors that remained independently associated
in the models. Women of older age (OR = 1.07; 95% CI
1.01–1.13), Italian (OR = 4.97; 95% CI 1.64–15.09), and
with a pregnancy at high-risk (OR = 11.43; 95% CI 2.22–
58.85) were more likely to know that influenza is more
dangerous for pregnant women. Moreover, this know-
ledge, when college degree or higher education was
chosen as reference category, was lower among those with
none/primary school (OR = 0.08; 95% CI = 0.02–0.36) or
secondary school level of education (OR = 0.11; 95% CI =
0.04–0.28) (Model 1).
With regard to attitudes, women feel dangerous for
them and for the unborn to contract the influenza dur-
ing pregnancy with a mean value respectively of 7.1 and
7.3, out of a maximum score of 10. Despite these per-
ceptions, the majority considered the influenza vaccine
during pregnancy not very useful with an average value
of 4.9, and feels the vaccine potentially dangerous for
their health (mean 6.7) or for the unborn (mean 7).
Table 1 Characteristics of the sample of pregnant women
Characteristics Number Percent





None or primary school 30 8.1
Secondary school 251 67.5










> 1 72 19.4
Week of pregnancy 26.7 ± 7.4(14-39)a
Number of previous pregnancies
0 173 46.5




Self-rated health status 7.1 ± 1.7(1-10)a
aMean ± standard deviation (range)
Table 2 Knowledge about influenza and its vaccination
Number Percent
The influenza is more dangerous for pregnant
women than for non-pregnant women
239 64.2
The vaccine could protect pregnant women
against the influenza
152 40.9
The influenza vaccine is recommended for
pregnant women
89 23.9
The influenza vaccine is recommended in the
second trimester of pregnancya
10 11.2
The influenza vaccine is recommended in
the third trimester of pregnancya
7 7.9
The influenza vaccine is safe during pregnancy 40 10.7
a Only for those who answered that the influenza vaccine is recommended for
pregnant women
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Multivariate linear regression analysis showed that those
younger, unmarried, who knew that influenza is more dan-
gerous for pregnant women, who knew that the vaccine
could protect pregnant women, who reported a higher self-
rated health status, and who had received information
about influenza and its vaccination were more likely to have
a positive attitude toward the usefulness of influenza vac-
cination during pregnancy. Moreover, women with second-
ary school level of education, compared to those with a
college degree or higher education, and those who have
more than one child, compared to those with no children,
revealed a lower perception towards the usefulness of vac-
cination during pregnancy (Model 2).
Only 9.7% of the women had received influenza vac-
cination and the most important reason for being vacci-
nated was the advice of the physician (88.9%), whereas,
for those unvaccinated the reasons most often men-
tioned were that they had not received information by
physicians (34.9%), fear that the vaccine would be harm-
ful (32.2%), and believed that the vaccine was not needed
(26.7%).
Among unvaccinated women, only 21.4% reported a
positive intention regarding vaccination during pregnancy.
Table 3 Multivariate logistic and linear regression analyses
indicating associations between independent variables and the
different outcomes
Variable OR SE 95% CI p value
Model 1. Knowledge that influenza is more dangerous for pregnant
women (sample size = 372)
Log likelihood = -186.11, χ2 = 116.25 (8 df), p < 0.0001
Educational level
College degree or higher 1a
None or primary school 0.08 0.06 0.02-0.36 0.001
Secondary school 0.11 0.05 0.04-0.28 <0.001
Having a high-risk pregnancy 11.43 9.55 2.22-
58.85
0.004
Italian nationality 4.97 2.81 1.64-
15.09
0.005
Age 1.07 0.03 1.01-1.13 0.011
Having received information about
influenza and its vaccination
1.65 0.44 0.97-2.79 0.06
Number of children
0 1a
1 1.67 0.47 0.96-2.91 0.07
Marital status 0.63 0.28 0.26-1.53 0.313
Variable Coeff. SE t p value
Model 2. Positive attitude towards the usefulness of the influenza
vaccine in pregnancy (sample size = 372)
F (12, 359) = 14.54, p < 0.0001, R2 = 0.32%, adjusted R2 = 0.3%
Age -0.09 0.02 -3.54 <0.001
Having received information about
influenza and its vaccination
1.06 0.23 4.57 <0.001
Knowledge that influenza is more
dangerous for pregnant women
0.66 0.29 2.23 <0.001
Knowledge that the vaccine could
protect pregnant women against
influenza
1.21 0.29 4.18 <0.001
Educational level
College degree or higher 1a
None or primary school 0.91 0.58 1.58 0.115
Secondary school -0.85 0.29 -2.89 0.004
Number of children
0 1a
> 1 -0.82 0.32 -2.58 0.01
Marital status -1.03 0.41 -2.56 0.011
Self-rated health status 0.15 0.07 2.15 0.033
Having a high-risk pregnancy 0.74 0.38 1.94 0.053
Perceive dangerous for the unborn if
the women contract the influenza
during pregnancy
0.06 0.05 1.05 0.295
Italian nationality 0.42 0.46 0.89 0.375
Table 3 Multivariate logistic and linear regression analyses
indicating associations between independent variables and the
different outcomes (Continued)
Variable OR SE 95% CI p value
Model 3. Positive attitude towards willingness to receive the influenza
vaccine in pregnancy (sample size = 336)
Log likelihood = -150.08, χ2 = 48.99 (11 df), p < 0.0001
Positive attitude toward the usefulness
of influenza vaccination in pregnancy
1.35 0.11 1.14-1.59 <0.001
Knowledge that the vaccine could
protect pregnant women against
influenza
3.03 1.24 1.35-6.77 0.007
Number of children
0 1a
1 2.41 0.92 1.15-5.08 0.02
> 1 3.34 1.62 1.29-8.67 0.013
Knowledge that influenza is more
dangerous for pregnant women
0.45 0.19 0.19-1.06 0.068
Italian nationality 2.58 1.59 0.77-8.62 0.122
Perceive dangerous for the unborn if
the women contract the influenza
during pregnancy
0.89 0.07 0.76-1.05 0.183
Self-rated health status 0.88 0.08 0.72-1.06 0.185
Educational level
College degree or higher 1a
Secondary school 1.44 0.52 0.71-2.92 0.306
Marital status 0.6 0.3 0.22-1.65 0.326
Age 0.97 0.03 0.91-1.03 0.364
aReference category
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Multivariate logistic regression analysis revealed that this
positive attitude was significantly higher among those who
had one (OR = 2.41; 95% CI = 1.15–5.08) or more than one
child (OR = 3.34; 95% CI = 1.29–8.67) compared to those
with no children, who knew that the vaccine could protect
pregnant women (OR = 3.03; 95% CI = 1.35-6.77), and who
have a positive attitude toward the usefulness of the vaccin-
ation during pregnancy (OR = 1.35; 95% CI = 1.14–1.59)
(Model 3). The most frequently selected reasons for the
positive attitude were the recommendation by the physician
(59.7%), that the influenza could be harmful for them
(15.9%) and for the unborn baby (19.4%). Reasons for
unwilling to receive the vaccine included concerns for the
unborn (65.4%) or for the pregnant woman (63.1%).
During their current pregnancy, only 40.3% had re-
ceived information about influenza and its vaccination
mainly by physicians (62%), internet (32.1%), and
mass media (6.6%). Moreover, the majority would like
to learn more about influenza (59.9%) and its vaccin-
ation (61.6%).
Discussion
So far as we know, this is the first time that has been
examined the level of knowledge, the awareness, and
the behavior about seasonal influenza and its vaccin-
ation and also the associated factors in a large group
of pregnant women in Italy.
It is important to consider that comparison with simi-
lar studies may be partly difficult due to differences
regarding the study design, the study period, the strat-
egies of the data collection, the different characteristics
of the populations sampled, and the public health
preventive activities. One of the main findings from this
study is that the overall knowledge and the vaccination
uptake were relatively poor. Indeed, less than two-thirds
answered that the influenza is more dangerous for preg-
nant women than for non-pregnant, less than half that
the vaccine could protect pregnant women, and one in
four that the vaccination is recommended during preg-
nancy. When compared to other studies, the observed
knowledge was higher. For example, in India none knew
about influenza vaccination requirement during preg-
nancy [34], in Canada 36% knew that influenza was
more severe in pregnant women [35], in the United
States 51% identified that seasonal flu is more dangerous
for pregnant women and 54% that the seasonal flu shot
is safe in pregnancy [17]. Similarly, in Australia 23% of
women believed that the vaccination during pregnancy
was not safe and 30% that it would not protect them
[19]. A considerably higher level of knowledge has been
observed in the United States with 77% pregnant women
who were aware that the vaccine is recommended [23]
and in Pakistan 75% acknowledged that the vaccine is
safe for pregnant women [24].
The present survey revealed a very low overall vaccin-
ation rate with a value of 9.7% and this of particular con-
cern. In theory, one would expect that this group have a
higher rate because of a better understanding of the
need to be vaccinated. However, this is not observed in
this sample. Therefore, it is important to design and to
implement interventions in order to increase the vaccin-
ation rate. The value observed in the present study is
higher than those reported in other countries, since no
women had received influenza vaccination in the already
mentioned study in India [34], 3% in Turkey [36], 4% in
Thailand [26], and it is almost identical to the 6% in Iran
[37], 10.9% in Germany [38], and 16% in Canada [39].
Whereas, it is substantially below the levels observed in
Australia with an uptake of 27% [20], in France of 39%
[40], in Belgium of 42.8% [41], and in the United States
with levels ranging from 35% [14] to 66.4% [42]. One of
the most commonly provided reasons by the unvaccin-
ated was that their doctor had not discussed during their
pregnancy. The finding that more than one third of
those unvaccinated did not receive a health care pro-
vider recommendation is in line with previous studies
[34, 36, 41, 43, 44]. Another commonly provided reason
was the concern that vaccination may not be safe during
pregnancy. Despite the extensive research demonstrating
vaccine safety, this is alarming and this is accordance
with previous studies [14, 17, 20, 40, 43, 45]. This
stressed the role of the physicians. Indeed, physicians
are an important channel for reaching pregnant
women and for delivering key messages in order to
contribute to improve the acceptance of the vaccine.
The finding regarding the sources of information
about influenza, which might improve the level of
knowledge and acceptance rate, showed that physi-
cians were the deeply trusted source and this has
been observed in previous studies [17, 21, 23, 36, 46].
Of the unvaccinated women, one-fifth indicated that
they intended to receive the vaccination during preg-
nancy. This value is almost identical to the 21.6%
found in the United States among pregnant minority
women [47]. By contrast, higher values have been ob-
served in the already mentioned survey in Thailand
with 42% of the women who reported being willing
to receive the seasonal influenza vaccine [26], in the
United States 82.8% said they would be immunized if
recommended by their physician [23], and in Pakistan
87% were willing to accept the vaccine [24].
Multivariate regression models have been developed for
estimating the association of individual characteristics and
specific outcomes of interest. Several socio-demographic
characteristics, including age, educational level, and mari-
tal status, resulted significantly associated with greater
knowledge and positive attitude. Women of older age had
higher level of knowledge and, not surprisingly, those with
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higher education level were more likely to know that
the influenza is dangerous for pregnant women and
to report a positive attitude towards the utility of the
vaccination during pregnancy. Prior study has shown
similar findings [38]. The fact that women with a
high-risk pregnancy were more likely to know that
the influenza is dangerous for pregnant can serve as a
focus when promoting health education interventions.
Moreover, an association has been identified between
knowledge concerning influenza and vaccination and
the attitude toward the usefulness of the vaccination
during pregnancy. Women with a better knowledge
had a significantly higher likelihood of having a posi-
tive attitude toward the usefulness of the vaccination
during pregnancy. Adequate knowledge and awareness
of a disease are the key prerequisites for its preven-
tion and control, given that adequate knowledge is a
basis for adopting appropriate attitudes and practices.
Care is required in interpreting the findings of this
study for potential limitations typical of population-
based questionnaire surveys. Firstly, it is difficult, as in
the cross-sectional studies, to precisely determine tem-
poral sequence between the dependent and independent
variables. Secondly, there was a possibility of bias due to
participants with favorable attitudes towards vaccination
potentially being more likely to respond to the question-
naire. This suggests that responses can be biased due to
forgetfulness or exaggeration of attitude and behaviors,
social desirability, or affected by feelings at the time of
the interview. Thirdly, the data were obtained from in-
terviews and the answers were not verified through chart
review and, therefore, it is not possible to be certain that
the respondents answered correctly and recall bias could
have occurred. Finally, a non-standardized questionnaire
has been used, although this limitation has been partially
solved by piloting the questions on a group of pregnant
women. Despite the mentioned limitations, the major
strength of the study resides in the high response rate,
making the results robust enough to be representative of
the population.
Conclusions
In conclusion, the low rate of vaccination and of women
who have expressed a positive attitude towards to re-
ceive the vaccine support the need to develop health
educational programs in order to improve the level of
knowledge about seasonal influenza and its vaccination
in this population focusing on the efficacy and safety.
Gynecologists and primary care physicians, who are the
providers of health care during pregnancy, with their
consultations and recommendations should play a more
substantial role in promoting this vaccination and to in-
crease the uptake in pregnant women.
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